A Part of the University of Maryland Medical Center

• General Information About Transitional Cell Cancer of the Renal Pelvis and Ureter
• Stages of Transitional Cell Cancer of the Renal Pelvis and Ureter
• Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
• Treatment Option Overview
• Treatment Options for Transitional Cell Cancer of the Renal Pelvis and Ureter
• To Learn More About Transitional Cell Cancer of the Renal Pelvis and Ureter

• Genitourinary Oncology

• Patient Care
• Diagnostic and Treatment Services
• Physicians and Staff
• Prostate Health Glossary
• Trilogy Radiation Therapy
• Robotic Prostatectomy
• Prostate Seed Implants
• Patient Education...
• 
    Related Resources
• Clinical Trials
• Information for Patients
• The Maryland Prostate Center

Treatment Options for Transitional Cell Cancer of the Renal Pelvis and Ureter

 

Ask the Expert

Get answers to your Kidney Cancer Surgery questions.

Dr. Richard Alexander’s Bio | Q&A Archive

Note: This is for informational purposes only. Doctors cannot provide a diagnosis or individual treatment advice via e-mail. Please consult your physician about your specific health care concerns.

 

A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.

Localized Transitional Cell Cancer of the Renal Pelvis and Ureter

Treatment of localized transitional cell cancer of the renal pelvis and ureter may include the following:

• Surgery (nephroureterectomy or segmental resection of ureter).
• A clinical trial of fulguration.
• A clinical trial of laser surgery.
• A clinical trial of segmental resection of the renal pelvis.
• A clinical trial of regional chemotherapy.
• A clinical trial of regional biologic therapy.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with localized transitional cell cancer of the renal pelvis and ureter. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Regional Transitional Cell Cancer of the Renal Pelvis and Ureter

Treatment of regional transitional cell cancer of the renal pelvis and ureter is usually done in a clinical trial.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with regional transitional cell cancer of the renal pelvis and ureter. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter

Treatment of metastatic transitional cell cancer of the renal pelvis and ureter is usually done in a clinical trial, which may include chemotherapy.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with metastatic transitional cell cancer of the renal pelvis and ureter. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter

Treatment of recurrent transitional cell cancer of the renal pelvis and ureter is usually done in a clinical trial, which may include chemotherapy.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent transitional cell cancer of the renal pelvis and ureter. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.